Sector: Consumer Non-Cyclicals | Industry: Food Processing |
Company Contact | |
Address: | 1000 Sherbrooke St W Suite 2700 MONTREAL QC H3A 3G4 |
Tel: | N/A |
Website: | https://releviumtechnologies.com |
IR: | See website |
Key People | ||
Aurelio Useche President, Chief Executive Officer, Director | Mark Billings Chief Financial Officer |
Business Overview |
Relevium Technologies Inc. is a Canada-based company, which operates in the health and wellness industry with a primary focus on online distribution. The principal business of the Company is the identification, evaluation, acquisition and operations of brands and businesses in the health and wellness markets with a focus on e-commerce. The Company operates through two wholly owned subsidiaries, BGX E-Health LLC and Biocannabix Health Corporation Inc. BGX E-Health LLC markets dietary supplements, nutraceuticals, sports nutrition, and cosmeceuticals, primarily through its Bioganix brand portfolio online in the United States. It provides a Push & Pull System by Bioganix. Push & Pull System is a comprehensive natural anti-aging system for complete skin care that combines collagen protein supplements (PUSH) and naturally sourced aloe vera skin anti-aging cream (PULL). |
Financial Overview |
For the nine months ended 31 March 2022, Relevium Technologies Inc revenues increased from C$700K to C$14M. Net income totaled C$1.4M vs. loss of C$1.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Selling and marketing decrease of 52% to C$275K (expense), General and administrative expenses decrease of 49% to C$257K (expense). |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $9.76M as of Mar 31, 2022 |
Annual revenue (TTM): | $14.25M as of Mar 31, 2022 |
EBITDA (TTM): | $1.13M as of Mar 31, 2022 |
Net annual income (TTM): | -$2.64M as of Mar 31, 2022 |
Free cash flow (TTM): | $22.05M as of Mar 31, 2022 |
Net Debt Last Fiscal Year: | $0.89M as of Mar 31, 2022 |
Shares outstanding: | 329,492,346 as of Mar 31, 2022 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |